April 12-15, 2018

Hilton Orlando Bonnet creek

The 23rd Annual Interventional Cardiology Fellows Course is sponsored by the Cardiovascular Research Foundation and partially funded through industry supporters.

The support from our industry colleagues, who, like the Cardiovascular Research Foundation, are dedicated to educating medical professionals and the public to enhance patient outcomes, helps to make this program possible.

The Cardiovascular Research Foundation gratefully acknowledges:

  • Abbott
  • Abiomed, Inc.
  • ACIST
  • Asahi Intecc USA, Inc.
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc.
  • Chiesi USA
  • Cordis, A Cardinal Health Company
  • Corindus Vascular Robotics
  • Edwards Lifesciences
  • Getinge Group
  • Medtronic
  • Philips Volcano
  • Spectranetics Corporation

The 23rd Annual Interventional Cardiology Fellows Course is sponsored by the Cardiovascular Research Foundation and partially funded through educational grants from commercial supporters.

The educational grant support of our industry colleagues, who, like the Cardiovascular Research Foundation, are dedicated to educating medical professionals and the public to enhance patient outcomes, helps to make this program possible.

The Cardiovascular Research Foundation gratefully acknowledges the Fellows Course

MAJOR BENEFACTORS:

  • Abbott
  • Boston Scientific Corporation
  • Medtronic

BENEFACTORS:

  • ABIOMED, Inc.
  • AstraZeneca
  • Cardiovascular Systems, Inc.
  • Chiesi USA, Inc.
  • Cordis, A Cardinal Health Company
  • Edwards Lifesciences
  • Spectranetics Corporation
  • St. Jude Medical, Inc.

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational programs. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.

A Revolutionary Approach to the Use of Percutaneous Hemodynamic Support Devices

Organized by the Cardiovascular Research Foundation
Sponsored by ABIOMED, Inc.

Hilton Orlando Bonnet Creek– Orlando, FL
Thursday, April 6, 2017

Citrus/Collier/Columbia, Lower Level

7:30 am - 8:00 am Check-in & Breakfast
8:00 am - 2:00 pm Program

Chairs

George W. Vetrovec, MD
VCU Pauley Heart Center
Richmond, VA

 

Faculty

Tony J. DeMartini, MD
Advocate Heart Institute
Springfield, IL

James M. McCabe, MD
University of Washington
Seattle, WA

Michael P. Flaherty, MD, PhD
University of Louisville School of Medicine
Louisville, KY

D. Lynn Morris, MD
Einstein Health Network
Philadelphia, PA

Anthony A. Hilliard, MD
Loma Linda University Medical Center
Loma Linda, CA

1

Raj A. Patel, MD
Ochsner Health System
New Orleans, LA

Sanjog Kalra, MD
Einstein Health Network
Philadelphia, PA

Alexander G. Truesdell, MD
Virginia Heart
Inova Heart and Vascular Institute
Fairfax, VA

Amir Kaki, MD
Detroit Medical Center
Detroit, MI

 

Agenda

8:00 am Welcome
George W. Vetrovec
  Complex PCI with hemodynamic Support: Identification and Treatment
  • 8:05 am
    Identifying the appropriate complex patient for Protected PCI
    George W. Vetrovec
  • 8:25 am
    Critical skills for patient management: Impella knowledge, placement competency and ICU management
    Anthony A. Hilliard
8:45 am What is the Appropriate Revascularization Strategy?
James M. McCabe
  • Hemodynamic Support provides a safe environment
9:05 am Role of Hemodynamic Support in Complex PCI
Sanjog Kalra
  Case Presentations on Protected PCI
  • 9:25 am
    CTO Supported PCI
    Tony J. DeMartini
  • 9:35 am
    UPLM or MVD with moderately reduced or normal EF
    Raj A. Patel
9:45 am Impella as a strategy to prevent acute kidney injury (AKI) during HRPCI
Michael P. Flaherty
10:00 am Break
  Access Techniques: Best Practices
  • 10:15 am
    Axillary Insertion of Impella
    James M. McCabe
  • 10:30 am
    Alternate Access
    Amir Kaki
10:45 am Essential Elements for Establishing a Protected PCI Program
Tony J. DeMartini
  • Heart Team Approach
  • Protocols and Algorithms
  • Outreach Programs
  Contemporary Look at the Treatment of Cardiogenic Shock
  • 11:00 am
    Management of shock - what is happening “under the hood” when treating patients with pressors, IABP, Impella and ECMO
    D. Lynn Morris
  • 11:15 am
    Choosing MCS Options in AMI Cardiogenic Shock: Rationale for Impella first
    Sanjog Kalra
  • 11:30 am
    Door-to-Unloading: A new quality metric
    Alex Truesdell
  • 11:45 am
    Practical Insights for adding hemodynamic support into your critical care path: The Detroit Cardiogenic Shock Initiative (CSI) Experience & Outcomes
    Amir Kaki
  • 12:05 pm
    Should every MCS patient have a RHC?
    Alex Truesdell
  Case Presentations on CGS
  • 12:25 pm
    Percutaneous Support Prior to PCI (A case from Detroit CSI)
    Amir Kaki
  • 12:40 pm
    Right and Left Ventricular Support
    D. Lynn Morris
1:00 pm-2:00pm Lunch and Hands-on Workshop